Upload Avatar (500 x 500)
Liu Libo
liulibo77@163.com
Chinese, English
Liaoning
China Medical University
Life Sciences
  • Liaoning Province Science and Technology Award Second Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
  • Liaoning Medical Science and Technology Award First Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
  • Shenyang Science and Technology Progress Award First Prize (2014): Regulation of Blood-Tumor Barrier Opening and Molecular Targeted Therapy of Glioma
Regulation of Blood-Tumor Barrier
Molecular Targeted Therapy of Glioma
  • AMG232 inhibits the angiogenesis in glioma through p53/RBM4/VEGFR2 pathway, Xiao Y, Ma T, Li ML, Ning H, Liu LB*, 2023
  • MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5, Chen LY, Xue YX, Zheng J, Liu XB, Liu J, Chen JJ, Li Z, Xi Z, Teng H, Wang P, Liu LB*, Liu YH*, 2018
  • Bradykinin increased the permeability of BTB via NOS/NO/ZONAB-mediating down-regulation of claudin-5 and occludin, Liu LB, Liu XB, Ma J, et al., 2015
  • Effects of Insulin Combined with Idebenone on the Blood-Brain Barrier Permeability in Diabetic Rats, Sun YN, Liu LB(co-first author), Xue YX, Wang P, 2015
Blood-Tumor Barrier Glioma Molecular Therapy Regulation Angiogenesis Vegfr2 P53 Rbm4 Emap-Ii Mir-429

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.